Laduviglusib (trihydrochloride), CAS [[1782235-14-6]]

Produktübersicht

• Artikelname: Laduviglusib (trihydrochloride), CAS [[1782235-14-6]]
• Artikelnummer: MCE-HY-10182B
• Hersteller Artikelnummer: HY-10182B
• Alternativnummer: MCE-HY-10182B-25MG,MCE-HY-10182B-100MG,MCE-HY-10182B-10MMX1ML,MCE-HY-10182B-50MG,MCE-HY-10182B-5MG,MCE-HY-10182B-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: CHIR-99021 (trihydrochloride), CT99021 trihydrochloride

Produktbeschreibung

Laduviglusib (CHIR-99021) trihydrochloride is a potent and selective GSK-3alpha/beta inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib trihydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib trihydrochloride is also a potent Wnt/beta-catenin signaling pathway activator. Laduviglusib trihydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib trihydrochloride induces autophagy[1][2][3].

Produkteigenschaften

• Molekulargewicht: 574.72
• Reinheit: 99.11
• CAS Nummer: [1782235-14-6]
• Formel: C22H21Cl5N8
• Target-Kategorie: Autophagy,GSK-3,Organoid,Wnt,beta-catenin

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound